1
|
Dupuit M, Chavanelle V, Chassaing B, Perriere F, Etienne M, Plissonneau C, Boscaro A, Barnich N, Pialoux V, Maugard T, Le Joubioux F, Peltier S, Sirvent P, Otero YF, Boisseau N. The TOTUM-63 Supplement and High-Intensity Interval Training Combination Limits Weight Gain, Improves Glycemic Control, and Influences the Composition of Gut Mucosa-Associated Bacteria in Rats on a High Fat Diet. Nutrients 2021; 13:nu13051569. [PMID: 34066988 PMCID: PMC8151333 DOI: 10.3390/nu13051569] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2021] [Revised: 04/30/2021] [Accepted: 05/02/2021] [Indexed: 12/12/2022] Open
Abstract
Obesity and prediabetes are the two strongest risk factors of type 2 diabetes. It has been reported that TOTUM-63, a polyphenol-rich plant extract, has beneficial effects on body weight (BW) and insulin resistance in mice fed a high fat diet (HFD). The study aim was to determine whether high-intensity interval training (HIIT) and/or TOTUM-63 supplementation improved body composition and glycemic control and gut microbiota composition in a Western diet-induced obesity rat model. Wistar rats received a standard diet (CTRL; control; n = 12) or HFD (HFD; n = 48) for 16 weeks. Then, HFD rats were divided in four groups: HFD, HFD + TOTUM-63 (T63), HFD + HIIT (HIIT), and HFD + HIIT +T63 (HIIT + T63). Training was performed 4 days/week for 12 weeks. TOTUM-63 was included in diet composition (2%). The HIIT + T63 combination significantly limited BW gain, without any energy intake modulation, and improved glycemic control. BW variation was correlated with increased α-diversity of the colon mucosa microbiota in the HIIT + T63 group. Moreover, the relative abundance of Anaeroplasma, Christensenellaceae and Oscillospira was higher in the HIIT + T63 group. Altogether, these results suggest that the HIIT and TOTUM-63 combination could be proposed for the management of obesity and prediabetes.
Collapse
Affiliation(s)
- Marine Dupuit
- Laboratoire des Adaptations Métaboliques à l’Exercice en conditions Physiologiques et Pathologiques (AME2P), Université Clermont Auvergne, CRNH Auvergne, 63000 Clermont-Ferrand, France; (M.D.); (M.E.); (C.P.); (A.B.)
| | - Vivien Chavanelle
- Valbiotis R&D, Riom Center, 63200 Riom, France; (V.C.); (P.S.); (Y.F.O.)
| | - Benoit Chassaing
- Inserm U1016, Team “Mucosal Microbiota in Chronic Inflammatory Diseases”, Université de Paris, CNRS UMR 8104, 75014 Paris, France;
| | - Fanny Perriere
- Laboratoire Microorganismes: Génome et Environnement (LMGE), Université Clermont Auvergne, CNRS, 63000 Clermont-Ferrand, France;
| | - Monique Etienne
- Laboratoire des Adaptations Métaboliques à l’Exercice en conditions Physiologiques et Pathologiques (AME2P), Université Clermont Auvergne, CRNH Auvergne, 63000 Clermont-Ferrand, France; (M.D.); (M.E.); (C.P.); (A.B.)
| | - Claire Plissonneau
- Laboratoire des Adaptations Métaboliques à l’Exercice en conditions Physiologiques et Pathologiques (AME2P), Université Clermont Auvergne, CRNH Auvergne, 63000 Clermont-Ferrand, France; (M.D.); (M.E.); (C.P.); (A.B.)
| | - Audrey Boscaro
- Laboratoire des Adaptations Métaboliques à l’Exercice en conditions Physiologiques et Pathologiques (AME2P), Université Clermont Auvergne, CRNH Auvergne, 63000 Clermont-Ferrand, France; (M.D.); (M.E.); (C.P.); (A.B.)
| | - Nicolas Barnich
- Microbes, Intestin, Inflammation et Susceptibilité de l’Hôte (M2iSH), UMR 1071 Inserm, USC-INRAE 2018, Université Clermont Auvergne, CRNH Auvergne, 63000 Clermont-Ferrand, France;
| | - Vincent Pialoux
- Laboratoire Interuniversitaire de la Biologie et de la Motricité (LIBM), Université Claude Bernard Lyon 1, EA 7424, 69266 Villeurbane, France;
| | - Thierry Maugard
- UMR 7266 CNRS-ULR, LIENSs, Equipe BCBS, La Rochelle Université, 17042 La Rochelle, France;
| | - Florian Le Joubioux
- Valbiotis R&D, La Rochelle Center, 17000 La Rochelle, France; (F.L.J.); (S.P.)
| | - Sébastien Peltier
- Valbiotis R&D, La Rochelle Center, 17000 La Rochelle, France; (F.L.J.); (S.P.)
| | - Pascal Sirvent
- Valbiotis R&D, Riom Center, 63200 Riom, France; (V.C.); (P.S.); (Y.F.O.)
| | - Yolanda F. Otero
- Valbiotis R&D, Riom Center, 63200 Riom, France; (V.C.); (P.S.); (Y.F.O.)
| | - Nathalie Boisseau
- Laboratoire des Adaptations Métaboliques à l’Exercice en conditions Physiologiques et Pathologiques (AME2P), Université Clermont Auvergne, CRNH Auvergne, 63000 Clermont-Ferrand, France; (M.D.); (M.E.); (C.P.); (A.B.)
- Correspondence: ; Tel.: +33-4-73-40-55-19
| |
Collapse
|